Metabolic reprogramming and two-compartment tumor metabolism: opposing role(s) of HIF1α and HIF2α in tumor-associated fibroblasts and human breast cancer cells
about
Cancer stem cell metabolismTargeting hypoxic response for cancer therapyPathophysiological mechanisms of death resistance in colorectal carcinomaOncogenes induce the cancer-associated fibroblast phenotype: metabolic symbiosis and "fibroblast addiction" are new therapeutic targets for drug discoveryThe ever-expanding role of HIF in tumour and stromal biologyHeptamethine carbocyanine dye-mediated near-infrared imaging of canine and human cancers through the HIF-1α/OATPs signaling axisCurrent views on cell metabolism in SDHx-related pheochromocytoma and paragangliomaSilencing of reversion-inducing cysteine-rich protein with Kazal motifs stimulates hyperplastic phenotypes through activation of epidermal growth factor receptor and hypoxia-inducible factor-2α.Analyses of the transcriptome and metabolome demonstrate that HIF1α mediates altered tumor metabolism in clear cell renal cell carcinoma.Chemotherapy induces the cancer-associated fibroblast phenotype, activating paracrine Hedgehog-GLI signalling in breast cancer cellsHIF isoforms have divergent effects on invasion, metastasis, metabolism and formation of lipid droplets.Mitochondria "fuel" breast cancer metabolism: fifteen markers of mitochondrial biogenesis label epithelial cancer cells, but are excluded from adjacent stromal cellsMitochondrial dysfunction in breast cancer cells prevents tumor growth: understanding chemoprevention with metformin.Creating a tumor-resistant microenvironment: cell-mediated delivery of TNFα completely prevents breast cancer tumor formation in vivo.Breast tumor and stromal cell responses to TGF-β and hypoxia in matrix deposition.Compartment-specific activation of PPARγ governs breast cancer tumor growth, via metabolic reprogramming and symbiosis.Carbonic anhydrase IX from cancer-associated fibroblasts drives epithelial-mesenchymal transition in prostate carcinoma cells.Targeting HIF2α translation with Tempol in VHL-deficient clear cell renal cell carcinoma.Cell-extrinsic consequences of epithelial stress: activation of protumorigenic tissue phenotypes.Hypoxia-Inducible Factor 2α Mutation-Related Paragangliomas Classify as Discrete Pseudohypoxic SubclusterOncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFκB target stromal MCT4.Targeting metabolic plasticity in breast cancer cells via mitochondrial complex I modulation.How cancer cells dictate their microenvironment: present roles of extracellular vesicles.Targeting mitochondrial function for the treatment of breast cancer.Roles of hypoxia, stem cells and epithelial-mesenchymal transition in the spread and treatment resistance of head and neck cancer.HIF2α is involved in the expansion of CXCR4-positive cancer stem-like cells in renal cell carcinoma.Cezanne regulates E2F1-dependent HIF2α expression.Targeting hypoxic cancer stem cells (CSCs) with Doxycycline: Implications for optimizing anti-angiogenic therapy.Cancer metabolism: new validated targets for drug discovery.Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development.Hypoxia inducible factor (HIF) in the tumor microenvironment: friend or foe?Hypoxia Pathway Proteins As Central Mediators of Metabolism in the Tumor Cells and Their Microenvironment.TP53-inducible Glycolysis and Apoptosis Regulator (TIGAR) Metabolically Reprograms Carcinoma and Stromal Cells in Breast Cancer.Angiogenesis in spontaneous tumors and implications for comparative tumor biology.HIF-1α and mTOR - Possible Novel Strategies of Targeted Therapies in p16-positive and -negative HNSCC.Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor X.Cancer stem cells (CSCs): metabolic strategies for their identification and eradication.Hypoxic Signalling in Tumour Stroma.Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts.Crosstalk between Notch, HIF-1α and GPER in Breast Cancer EMT
P2860
Q26746123-F2C9496F-C57A-469E-A34A-C2FC12249DADQ26767351-CD211246-A9E1-492C-BA01-3551A4D28760Q26778007-429445DC-D20F-447D-94BA-DDB8F49CB54EQ26851813-428C7B54-053C-4D06-A4A7-5952A0669EBFQ28079015-5F8E8A26-AFD7-4931-87AA-AD0D75A7FDFBQ30303040-2D48E53E-73B0-46EB-8BB8-EB329ED86EC4Q33590969-5077455C-ED80-461C-A4D6-EE53B322BC15Q35078415-7F8B4E3B-D157-4056-B373-AAD06AACC09CQ35591773-1E0B7427-48B9-4F4D-8C73-DDDAA5DE03A7Q35793591-2C785204-06A1-405A-87A1-41374E88E348Q36413992-C3CE4943-106A-4097-BEAC-E6C08DE11CE2Q36556326-8D0EC282-5D37-49CB-88A3-ED0E86643B2EQ36604623-2ED984E2-189E-48E0-BC2B-2AEAF512AFB8Q36654392-1B8553BB-4531-4677-9699-328AA33E7531Q36736295-F785DDE8-B57C-4164-AA99-1C3D8B4DC16CQ36906190-F9034001-5289-4A45-BA41-63649AADE3AEQ37018260-84A35611-D9B6-4BCC-84CF-849D69BFA404Q37030920-0166AFC5-B562-40F2-8F60-8A0A7E603DBAQ37205669-4AF02A5D-89A0-4518-94E1-7B5001B6F51EQ37273892-1A28D268-BCEB-418D-AB7C-41953A1DF91DQ37396904-5225512D-3853-4024-88FE-78B852F8ACD8Q37452112-A1CEEC4D-7B63-4566-B145-7B9720D65E73Q37610824-AF5199E5-9850-43B6-94F6-5E8596010733Q38264534-C28C2758-3741-43E7-BD2B-86EFE02C70BDQ38465117-0617E94C-004F-48D8-9B39-103DA6BF5603Q38830081-6C751305-7FD7-45EA-B7D6-7E8BA27CC067Q40764538-ACA26FC1-9FBE-4608-9AE7-1F262693CFC7Q41347692-2BB1EE21-534D-426C-81DB-C76681FF655EQ42962693-395FAF35-C436-47A9-BAA3-F647ED07246BQ47285805-E06595D2-43DC-4F5C-AE55-7B1F91750CE8Q47893488-08614F0C-960C-4564-BDC6-8FCD29F92B1FQ49725890-E9A2CFDD-EC44-4639-B52E-789BE4974B6DQ49727332-8975F200-9D09-4F6E-B6AD-BEB510B255CCQ51301228-40EA81D4-6864-40B6-8EC5-BB133582988BQ52563042-14FDB59E-E616-4464-94C6-F993E2EE0CC5Q53060298-D900BBEC-170C-4C03-BF6B-7600B91CBD35Q55254924-F40A4ECB-8743-493D-8A69-E0C15A234960Q55284922-4960FACA-325B-4762-933F-395CE0BC6224Q55412562-A71018B3-8933-4BF0-8B32-9AE143134168Q57109688-FB9A1587-C4DE-45C6-BCB4-53D4FE43A76D
P2860
Metabolic reprogramming and two-compartment tumor metabolism: opposing role(s) of HIF1α and HIF2α in tumor-associated fibroblasts and human breast cancer cells
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Metabolic reprogramming and tw ...... and human breast cancer cells
@ast
Metabolic reprogramming and tw ...... and human breast cancer cells
@en
type
label
Metabolic reprogramming and tw ...... and human breast cancer cells
@ast
Metabolic reprogramming and tw ...... and human breast cancer cells
@en
prefLabel
Metabolic reprogramming and tw ...... and human breast cancer cells
@ast
Metabolic reprogramming and tw ...... and human breast cancer cells
@en
P2093
P2860
P50
P356
P1433
P1476
Metabolic reprogramming and tw ...... and human breast cancer cells
@en
P2093
Anthony Howell
Barbara Chiavarina
Richard G Pestell
Ubaldo E Martinez-Outschoorn
P2860
P304
P356
10.4161/CC.21643
P577
2012-08-16T00:00:00Z